BONORA, BENEDETTA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.867
EU - Europa 375
AS - Asia 230
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
OC - Oceania 2
SA - Sud America 1
Totale 3.481
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.859
IT - Italia 196
CN - Cina 166
SE - Svezia 50
FI - Finlandia 40
GB - Regno Unito 25
IN - India 22
DE - Germania 21
VN - Vietnam 18
IE - Irlanda 11
FR - Francia 10
UA - Ucraina 7
CA - Canada 5
KR - Corea 5
EU - Europa 4
TR - Turchia 4
HK - Hong Kong 3
JP - Giappone 3
MK - Macedonia 3
MX - Messico 3
NL - Olanda 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
EG - Egitto 2
ES - Italia 2
SA - Arabia Saudita 2
TW - Taiwan 2
AU - Australia 1
BR - Brasile 1
DK - Danimarca 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.481
Salva come PNG Salva come JPEG
Città #
Fairfield 555
Chandler 334
Woodbridge 249
Houston 225
Cambridge 205
Ashburn 192
Seattle 183
Ann Arbor 149
Wilmington 145
San Diego 84
Medford 49
Princeton 49
Padova 42
Roxbury 42
Beijing 37
New York 36
Des Moines 35
Helsinki 28
Milan 21
Dong Ket 18
Dearborn 17
Guangzhou 14
Shanghai 13
Jacksonville 12
Nanjing 12
Redmond 12
Shenyang 12
Boardman 10
Dublin 9
Paris 8
Hebei 7
Selvazzano Dentro 7
Sommacampagna 7
Hefei 6
Kunming 6
Nanchang 6
Pune 6
Breganze 5
London 5
Los Angeles 5
Redwood City 5
Rome 5
Vicenza 5
Bologna 4
Guiglia 4
Hangzhou 4
Jinan 4
Naples 4
New Delhi 4
Ningbo 4
Ogden 4
Oristano 4
Rockville 4
Tianjin 4
Auburn Hills 3
Boston 3
Cerveteri 3
Hyderabad 3
Istanbul 3
Pravisdomini 3
Santa Maria Chimalhuacan 3
Skopje 3
Taizhou 3
Zhengzhou 3
Adrara San Martino 2
Aprilia 2
Borås 2
Changsha 2
Chiswick 2
Delhi 2
Duncan 2
Formello 2
Fuzhou 2
Gangseo-gu 2
Genoa 2
Gent 2
Gwangmyeong 2
Jiaxing 2
Kafr ash Shaykh 2
Kaohsiung City 2
Kharkiv 2
Nakhon Ratchasima 2
Norwalk 2
Orange 2
Ottawa 2
Parma 2
Pisa 2
Qingdao 2
Rovigo 2
Santa Lucia Di Piave 2
Scafati 2
Trento 2
Abano Terme 1
Acton 1
Ambli 1
Amsterdam 1
Bangkok 1
Bratislava 1
Brighton 1
Chaoyang 1
Totale 3.010
Salva come PNG Salva come JPEG
Nome #
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 158
Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes 154
NETosis is induced by high glucose and associated with type 2 diabetes. 141
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial 140
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 133
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 120
SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System 114
DPP-4 inhibitors moderate the risk of genitourinary tract infections associated with SGLT2 inhibitors 110
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 109
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 101
Synergistic Interactions Among Metabolic Syndrome Components and Homeostasis Model Assessment of Insulin Resistance in a Middle-Aged General Population over Time. 99
Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical Aspects 90
Subclinical Hypothyroidism and Metabolic Syndrome: A Common Association by Chance or a Cardiovascular Risk Driver? 90
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 86
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: A randomized placebo-controlled trial 85
Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects 84
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes 84
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 83
Tocilizumab for severe COVID-19 pneumonia 82
Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care 82
Shift of monocyte subsets along their continuum predicts cardiovascular outcomes 76
Effects of exenatide long-acting release on cardiovascular events and mortality in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials 73
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis 71
Effects of SGLT2 inhibitors on circulating stem and progenitor cells in patients with type 2 diabetes 70
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications 68
Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature 67
Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes 67
Effects of Age, Diabetes, and Vascular Disease on Growth Differentiation Factor 11: First-in-Human Study 66
Exposure to insulin degludec during pregnancy: report of a small series and review of the literature 64
Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes 59
Diabetes mellitus impairs circulating proangiogenic granulocytes 54
Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial 54
Effects of Hypoglycemia on Circulating Stem and Progenitor Cells in Diabetic Patients 51
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy 51
Comparative effectiveness of exenatide once-weekly versus liraglutide in routine clinical practice: A retrospective multicentre study and meta-analysis of observational studies 50
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial 48
Circulating stem cells and cardiovascular outcomes: from basic science to the clinic 47
Effects of glucose variability on hematopoietic stem/progenitor cells in patients with type 1 diabetes 45
Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps 40
Extraglycemic effects of SGLT2 inhibitors: A review of the evidence 37
Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 33
Euglycemic Ketoacidosis 32
The Toll of Lockdown Against COVID-19 on Diabetes Outpatient Care: Analysis From an Outbreak Area in Northeast Italy 32
Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of COVID-19: narrative review and meta-analysis 32
SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system 24
Why diabetes outpatient clinics should not close during pandemic crises 19
Glycaemic Control Achieves Sustained Increases of Circulating Endothelial Progenitor Cells in Patients Hospitalized for Decompensated Diabetes: An Observational Study 17
Managing diabetes in diabetic patients with COVID: where do we start from? 14
Hematopoietic progenitor cell liabilities and alarmins S100A8/A9-related inflammaging associate with frailty and predict poor cardiovascular outcomes in older adults 12
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care 11
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studies 11
Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features 5
Circulating stem cells and cardiovascular outcomes: from basic science to the clinic 5
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study 4
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells 2
Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review 1
Ketosis-prone Diabetes and Hypogonadism: A New Clinical Association to be Aware of ? 1
Circulating haematopoietic stem cells and long-term outcomes of COVID-19 1
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 1
Totale 3.560
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.578
article - articoli 14.578
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019137 0 0 0 0 0 0 0 0 0 0 64 73
2019/2020608 44 17 7 73 57 52 96 61 66 44 62 29
2020/2021912 41 48 68 79 54 35 19 64 84 238 90 92
2021/2022789 43 72 78 52 85 55 31 64 71 20 40 178
2022/2023591 127 79 15 67 73 70 5 55 53 13 32 2
2023/2024286 9 44 41 27 13 61 25 19 31 14 2 0
Totale 3.560